Last year's June issue of Genome Technology included a feature story that delved into the world of venture capital in the life sciences. Even a year ago, the marketplace for new life science startup companies was becoming a bit tighter than it had been in the past, though investments were still being made. In the first quarter of 2008, four venture-backed life science companies went public and, according to PricewaterhouseCooper's MoneyTree, $1.08 billion was invested in 132 biotechnology deals during that time.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.